63. The Participation of German Physicians in the So-Called "Euthanasia Program" During the Third Reich: Motivations, Verdicts, and Sentences Robert McKelvey, M.D.

64. Development of a Comorbidity Index for Mental Health Dianne Groll, Ph.D.

65. Dreaming With Jung: Carl Jung's Red Book and Critical Implications for Psychiatric Practice 90 Years Later Scott Simpson, M.D., M.P.H.

66. Risks of Readmission in Patients Diagnosed With Bipolar, Major Depressive, or Schizoaffective Disorders: A Longitudinal Study Stephen Woolley, D.Sc., M.P.H.

Anxiety Disorder in Children and Adolescents: State-of-the-Art Assessment and Treatment John Walkup, M.D.

Posttraumatic Stress Disorder, Major Depression, and the Risk for Suicidal Behavior Maria Oquendo, M.D.

Successful Cognitive Aging and Wisdom Dilip V. Jeste, M.D.

Depression and Diabetes: Unhealthy Bedfellows Wayne Katon, M.D.

Collaborative Care for College Students: The National College Depression Partnership (NCDP) Henry Chung, M.D.

Health Plan Implementation of Primary Care–Based Behavioral Health Services Hyong Un, M.D.

Improving Mental Health Care for Medical Outpatients: A Co-Location Model Using Psychiatrists in Urban Primary Care Settings Bruce Schwartz, M.D.

Improving Medical Care of Patients Receiving Behavioral Health Care Joseph Parks, M.D.

Achieving Comprehensive, Sustainable Models of Care in the Patient-Centered Medical Home Under Health Care Reform Frank Degruy, M.D.

Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center John Bradley, M.D.

Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center Scott Moran, M.D.

The Pacific Psychological Health Task Force: Enhancing Treatment Through Establishment of Partnerships in the Pacific Region Carroll Diebold, M.D.

Pharmacotherapy for PTSD in Combat Veterans: Challenges and Opportunities David Benedek, M.D.

Building DoD/VA/State and Community Partnership in Service to OEF/OIF Veterans and Their Families: Military Culture and Community Competence Harold Kudler, M.D.

Teaching Neuroscience to Psychiatry Residents: What to Teach and How to Teach It Mayada Akil, M.D.

Integrating Neuroscience in the Training of Psychiatrists: The Yale Experience David Ross, M.D., Ph.D.

Organizing a Neuroscience Course Around the Research Domain Criteria Project (RDoC) Amit Etkin, M.D., Ph.D.

Increasing the Validity of Animal Models of Depression by Genetic-Environment Interactions Irwin Lucki, Ph.D.

New Drugs to No Drugs: Antidepressants and Drug Discovery/Development David Michelson, M.D.

Cross-Species Tests for Cognition Enhancement in Schizophrenia Mark Geyer, Ph.D.

Alzheimer's Disease Clinical Trial Failures: Ineffective Drugs or Flawed Clinical Trials? Nigel Greig, Ph.D.

Whole Person Care in Psychiatry and in Palliative Medicine John Peteet, M.D.

Clinical Implications of Research on Healthy Personality Functioning C. Robert Cloninger, M.D.

Patient Preferences and Values: The Connecting Thread Between Evidence-Based Medicine and Cultural Competence Francis Lu, M.D.

Spirituality and Health: Guidelines for Clinical Care and Curriculum Development Christina Puchalski, M.D.

Comprehensive Treatment of Complex Patients: The Psychiatrist's Role Nadine Nyhus, M.D., M.A.

How to Do a Biopsychosocial Formulation and Use Diagnostic Reasoning and Clinical Decision Making That Involve the Family Alison Heru, M.D.

Different Models of Family Intervention and Their Application to Psychiatric Disorders, Symptoms, and Situations Ira Glick, M.D.

Stalking of Health Care Professionals: Reducing the Risk Gail E. Robinson, M.D.

Treatment of Stalkers Werner Tschan, M.D.

Stalking Behavior Among Juveniles: Opportunities for Early Intervention Rosemary Purcell, Ph.D.

Assessment and Management of Stalking and Threatening Activity in Campus Settings Mario Scalora, Ph.D.

Patient-Reported Outcome Measures in DSM-5 William Narrow, M.D., M.P.H.

Patient Reported Outcomes Measurement Information System (PROMIS): Overview and Applications for Mental Health Research William Riley, Ph.D.

Patient-Reported Outcome Measure in Clinical Trials—An FDA Perspective June Cai, M.D.

International Pilot Study on Patient-Reported Outcomes in Schizophrenia Massimo Moscarelli, M.D.

Parental Viewpoints on Trajectories to the Development of Borderline Personality Disorder in Males Marianne Goodman, M.D.

Rates of Recurrence of the Symptoms of BPD after Sustained Symptomatic Remission Mary Zanarini, Ed.D.

Prospective Predictors of Suicide Attempts in Borderline Personality Disorder at Six-Year Follow-Up Paul Soloff, M.D.

Prospective Risk Factors for Suicide Attempts in a Treated Sample of Patients With Borderline Personality Disorder (BPD) Paul Links, M.D.

Characteristics and Impact of De- and Re-Institutionalization in Western Europe Joséphine Caubel, M.D.

Cities as Creators of Madness Wilco Tuinebreijer, M.D.

Integrative Care: The Way From Hospital to Outpatient Settings in Germany Jürgen Gallinat, Ph.D., M.D.

Birmingham: An Integrated Model of Hospital and Community Mental Health Service Provision Mervyn Morris, M.A., Ed.D.

Assertive Community Treatment in Amsterdam: The Dutch Answer to Deinstitutionalization Jeroen Zoeteman, M.D.

The Psychology and Psychodynamics of the Placebo Response Javier Garcia, M.D.

Placebo Effect in Clinical Trials Intikhab Ahmad, M.D.

Ethical Dilemmas in the Use of Placebo Joel Idowu, M.D.

The Neurobiology of Placebo Effects William Head, M.D.

The Placebo Effects in Clinical Practice Sheldon Blackman, Ph.D.

67. Visualizing Mental Diseases: Distinct Plasma Levels of Cytokines and Chamokines in Schizophrenia and Major Depressive Disorder Sekiyama Atsuo, M.D., Ph.D.

68. Conversion Disorder Presenting as Hemiplegia in a Patient With Familial Hemiplegic Migraine George Paris, M.D.

69. Diagnostic Stability in Major Depressive Disorder With Versus Without Psychotic Features John Goethe, M.D.

70. Bruxism and Antidepressants Harvinder Singh, M.D.

71. Rapid Response of Disabling Tardive Dyskinesia to a Short Course of Amantadine Gaurav Jain, M.D.

72. Current Prescribing Practices: Antipsychotic Polypharmacy in Patients With Schizophrenia and Schizoaffective Disorder John Bonetti, D.O.

73. Prescription Rates of Selective Serotonin Reuptake Inhibitors (SSRIs) After Introduction of Generic Equivalents: A Population-Based Study James Bolton, M.D.

74. Parsing the Heterogeneity of Schizophrenia: The Utility of Four Early-Course Features in Subtyping First-Episode Nonaffective Psychosis Michael Compton, M.D., M.P.H.

75. Mood Symptoms in Patients Presenting With Primary Psychosis After Age 40: A Prospective Cohort Study Rebecca Anglin, M.D.

76. A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk Thomas Stroup, M.D., M.P.H.

77. Meta-analysis of Phase 3 Trials of Iloperidone in the Short-Term Treatment of Schizophrenia: Efficacy Outcomes Based on Pretreatment Status Stephen Stahl, M.D., Ph.D.

1. Psychotherapies for Hyperarousal and Dissociative Subtypes of PTSD: Similarities and Differences David Spiegel, M.D.

3. Psychotherapy With Suicidal Patients Barbara H. Stanley, Ph.D.

4. Psychotherapy Plus: Medication for Addictive Disorders Charles O'Brien, M.D., Ph.D.

5. Psychotherapy Induces Proliferation of Brain Serotonin 5-HT1A Receptors but Does Not Influence Dopamine D2/3 Receptors in Patients With Major Depressive Disorder Hasse Karlsson, M.D., Ph.D.

Reconsolidation Blockade as a Novel Strategy for Treating PTSD Charles Marmar, M.D.

Targeting Peptides for Novel Pharmacological Treatments of PTSD Thomas Neylan, M.D.

Neuroscience Informed Strategies for Early Intervention for PTSD Arieh Y. Shalev, M.D.

Interrupting the Intergenerational Transmission of Trauma by Treating Maternal PTSD and Optimizing Maternal Care Claude M. Chemtob, Ph.D.

HIV/AIDS Medical Update The Very Right Rev. Drew A. Kovach, M.D., M.Div.

Neuropsychiatric Overview Marshall Forstein, M.D.

Neurocognitive Decline Karl Goodkin, M.D., Ph.D.

Psychopharmacology Stephen Ferrando, M.D.

New Insight Into the Neurobiology of Depression and the Development of Rapid-Acting Antidepressants and Biomarkers of Response Carlos Zarate, M.D.

Combining Medications to Enhance Depression Outcomes (CO-MED) Madhukar Trivedi, M.D.

TMS, Magnetic Seizure Therapy in Animals Holly Lisanby, M.D.

The NIMH Bipolar Trials Network Lithium Treatment Moderate Dose Use Study (LiTMUS): A Randomized, Comparative Effectiveness Trial of Adjunctive Lithium Joseph Calabrese, M.D.

The Experience of Soul/Atman/Center/Hara/Seika Tanden/Spirit as an Essential Element of Being Necessary for Flourishing to Progress to Recovery Carl C. Bell, M.D.

The Impact of Health Reform on the Recovery Movement in America Steven Sharfstein, M.D., M.P.A.

Recovery: Practical and Policy Lessons From Around the World Jair Mari, M.D.

Recovery, Psychiatry, and Federal Mental Health Policy in the U.S. Kenneth Thompson, M.D.

Treatment-Resistant Depression: Overview of the University of Michigan Depression Center Roadmap John F. Greden, M.D.

Psychopharmacological Roadmap for Treatment-Resistant Depression Srijan Sen, M.D.

Treatment-Resistant Depression Among Adolescents Neera Ghaziuddin, M.D.

Treatment-Resistant Depression: A Roadmap for Effective Care Michelle B. Riba, M.D.

Device-Related Neuromodulation in Treatment-Resistant Depression Daniel Maixner, M.D.

Important Clinical and Legal Concepts Pertaining to Psychiatric Malpractice Craig Beach, M.D., M.Sc.

Cases to Illustrate Practical Strategies to Minimize Malpractice Risk and Navigate the Legal System in the Event of a Lawsuit Praveen Kambam, M.D.

What Really Occurs During a Malpractice Action Louis DelSignore, J.D.

Potential Emotional, Ethical, and Practical Implications of Being Sued Carolyn Wolf, J.D., M.S.

Challenges and Conflicts in Professional Leadership at Psychiatric Institutions Robert Michels, M.D.

The Evolving Clinical-Administrative Function Richard Munich, M.D.

Human Genotypic and Phenotypic Adaptations to Their Environments Jimmie Harris, D.O.

fMRI Evidence for Multisensory Recruitment Associated With Rapid Eye Movements During Sleep Charles Chong-Hwa Hong, M.D., Ph.D.

Imaging Correlates of Lucid Dreaming Renate Wehrle, Ph.D.

Quantitative EEG Correlates of Lucid Dreaming Ursula Voss, Ph.D.

More Childhood-Onset Bipolar Illness in the U.S. Than in Europe Robert Post, M.D.

Bipolar Disorder: Under- or Overdiagnosed Jean Michel Azorin, M.D.

Bipolar Disorder in Youth: Controversies in the U.S. and Abroad Robert Hendren, D.O.

Treatment Recommendations: The French Experience Philippe Courtet, M.D., Ph.D.

Prevalence and Characteristics of Bipolar Disorders in Patients With a Major Depressive Episode Charles Bowden, M.D.

The Challenge of Bipolar Depression Diagnosis and Treatment François Petitjean, M.D.

Psychiatric and Behavioral Genetics and the Eugenic Legacy Paul S. Appelbaum, M.D.

Prenatal Genetic Screening for Psychiatric Disorders and Behavioral Traits Mildred Cho, Ph.D.

Newborn Genetic Screening: Legal and Ethical Concerns Steven Hoge, M.D., M.B.A.

Is Epigenetics a New Paradigm for Understanding Behavior? Nancy Press, Ph.D.

Ethical Issues in Psychopharmacogenetic Testing Jinger Hoop, M.D.

Mentalization Based Treatment (MBT) and its Relationship to Other Psychotherapies for Borderline Personality Disorder Anthony Bateman, M.D.

Transference-Focused Psychotherapy: The Relationship in the Here-and-Now as the Key Frank Yeomans, M.D., Ph.D.

Dialectical Behavior Therapy Linda Dimeff, Ph.D.

TARA DBT-MBT Family Training Valerie Porr, M.A.

Predictors, Moderators, and Mediators of Symptom Improvement in Major Depressive Disorder: Focus on Clinical Factors George Papakostas, M.D.

Pharmacogenomics of Major Depression Julio Licinio, M.D.

Phosphorus-31 MRS Studies of High Energy Phosphates in MDD: Implications for Treatment Response and Novel Therapies Perry Renshaw, M.D., Ph.D.

Neurophysiologic Biomarkers for Predicting Treatment Outcome in MDD Andrew Leuchter, M.D.

ATR-A QEEG-Based Biomarker of Treatment Response in Major Depression Dan Iosifescu, M.D., M.Sc.

Referenced-EEG (rEEG) Daniel Hoffman, M.D.

iSPOT Evian Gordon, Ph.D.

Personality and Life Events as Predictive Factors of Suicidal Behavior Hilario Blasco-Fontecilla, M.D., Ph.D.

Predictive Models in Suicidal Behavior Jorge Lopez-Castroman, M.D., Ph.D.

Novel Classification Tools for Suicide Prediction Fernando Perez-Cruz, B.Sc.

Data Mining, Suicide, and More: Our Experience M. Mercedes Perez-Rodriguez, M.D., Ph.D.

Implementation of All These Novel Tools in the Prevention of Suicide Jose de Leon, M.D.

Overview of Topic Fred C. Osher, M.D.

The Judge's Role Steven Leifman, J.D.

Collaborative Strategies Between Psychiatrists and Judges to Improve Outcomes for Defendants With Mental Illnesses Annelle Primm, M.D., M.P.H.

How the Issue Impacts Hawaiians Marcia Waldorf, J.D.